UniProt ID | RANG_HUMAN | |
---|---|---|
UniProt AC | P43487 | |
Protein Name | Ran-specific GTPase-activating protein | |
Gene Name | RANBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 201 | |
Subcellular Localization | ||
Protein Description | Plays a role in RAN-dependent nucleocytoplasmic transport. Alleviates the TNPO1-dependent inhibition of RAN GTPase activity and mediates the dissociation of RAN from proteins involved in transport into the nucleus (By similarity). Induces a conformation change in the complex formed by XPO1 and RAN that triggers the release of the nuclear export signal of cargo proteins. [PubMed: 20485264 Promotes the disassembly of the complex formed by RAN and importin beta. Promotes dissociation of RAN from a complex with KPNA2 and CSE1L (By similarity Required for normal mitotic spindle assembly and normal progress through mitosis via its effect on RAN] | |
Protein Sequence | MAAAKDTHEDHDTSTENTDESNHDPQFEPIVSLPEQEIKTLEEDEEELFKMRAKLFRFASENDLPEWKERGTGDVKLLKHKEKGAIRLLMRRDKTLKICANHYITPMMELKPNAGSDRAWVWNTHADFADECPKPELLAIRFLNAENAQKFKTKFEECRKEIEEREKKAGSGKNDHAEKVAEKLEALSVKEETKEDAEEKQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAKDTHE ------CCCCCCCCC | 19.00 | 19413330 | |
5 | Acetylation | ---MAAAKDTHEDHD ---CCCCCCCCCCCC | 59.44 | 23954790 | |
7 | Phosphorylation | -MAAAKDTHEDHDTS -CCCCCCCCCCCCCC | 26.85 | 26503892 | |
13 | Phosphorylation | DTHEDHDTSTENTDE CCCCCCCCCCCCCCC | 33.84 | 22167270 | |
14 | Phosphorylation | THEDHDTSTENTDES CCCCCCCCCCCCCCC | 39.52 | 22167270 | |
15 | Phosphorylation | HEDHDTSTENTDESN CCCCCCCCCCCCCCC | 35.03 | 22167270 | |
18 | Phosphorylation | HDTSTENTDESNHDP CCCCCCCCCCCCCCC | 34.61 | 22167270 | |
21 | Phosphorylation | STENTDESNHDPQFE CCCCCCCCCCCCCCC | 42.13 | 22167270 | |
32 | Phosphorylation | PQFEPIVSLPEQEIK CCCCCCCCCCHHHCC | 38.64 | 23927012 | |
39 | Ubiquitination | SLPEQEIKTLEEDEE CCCHHHCCCCHHCHH | 46.43 | - | |
50 | Acetylation | EDEEELFKMRAKLFR HCHHHHHHHHHHHHH | 39.85 | 23236377 | |
50 | Ubiquitination | EDEEELFKMRAKLFR HCHHHHHHHHHHHHH | 39.85 | - | |
54 | Acetylation | ELFKMRAKLFRFASE HHHHHHHHHHHHHCC | 37.48 | 18527719 | |
60 | Phosphorylation | AKLFRFASENDLPEW HHHHHHHCCCCCHHH | 33.93 | 19664994 | |
68 | Ubiquitination | ENDLPEWKERGTGDV CCCCHHHHHCCCCCC | 35.55 | 21890473 | |
68 | Acetylation | ENDLPEWKERGTGDV CCCCHHHHHCCCCCC | 35.55 | 25953088 | |
68 | Ubiquitination | ENDLPEWKERGTGDV CCCCHHHHHCCCCCC | 35.55 | 21890473 | |
68 | Methylation | ENDLPEWKERGTGDV CCCCHHHHHCCCCCC | 35.55 | 18527727 | |
76 | Ubiquitination | ERGTGDVKLLKHKEK HCCCCCCEEECHHHH | 53.49 | 21890473 | |
76 | Ubiquitination | ERGTGDVKLLKHKEK HCCCCCCEEECHHHH | 53.49 | 21890473 | |
76 | Acetylation | ERGTGDVKLLKHKEK HCCCCCCEEECHHHH | 53.49 | 25953088 | |
79 | Acetylation | TGDVKLLKHKEKGAI CCCCEEECHHHHHHH | 64.17 | 18527735 | |
97 | Acetylation | MRRDKTLKICANHYI HCCCCCHHHHCCCCC | 40.76 | 25953088 | |
99 | Glutathionylation | RDKTLKICANHYITP CCCCHHHHCCCCCCC | 2.72 | 22555962 | |
103 | Phosphorylation | LKICANHYITPMMEL HHHHCCCCCCCCEEC | 13.29 | 28796482 | |
105 | Phosphorylation | ICANHYITPMMELKP HHCCCCCCCCEECCC | 9.66 | - | |
111 | Ubiquitination | ITPMMELKPNAGSDR CCCCEECCCCCCCCC | 23.95 | 21906983 | |
111 | Ubiquitination | ITPMMELKPNAGSDR CCCCEECCCCCCCCC | 23.95 | 21890473 | |
111 | Acetylation | ITPMMELKPNAGSDR CCCCEECCCCCCCCC | 23.95 | 20167786 | |
132 | Glutathionylation | HADFADECPKPELLA CCCCCHHCCCHHHEE | 5.59 | 22555962 | |
134 | Acetylation | DFADECPKPELLAIR CCCHHCCCHHHEEHE | 63.88 | 23954790 | |
134 | Ubiquitination | DFADECPKPELLAIR CCCHHCCCHHHEEHE | 63.88 | 21906983 | |
134 | Ubiquitination | DFADECPKPELLAIR CCCHHCCCHHHEEHE | 63.88 | 21890473 | |
137 | Phosphorylation | DECPKPELLAIRFLN HHCCCHHHEEHEECC | 5.48 | 27251275 | |
150 | Ubiquitination | LNAENAQKFKTKFEE CCHHHHHHHHHHHHH | 46.55 | 21890473 | |
150 | Acetylation | LNAENAQKFKTKFEE CCHHHHHHHHHHHHH | 46.55 | 19608861 | |
150 | Succinylation | LNAENAQKFKTKFEE CCHHHHHHHHHHHHH | 46.55 | - | |
150 | Succinylation | LNAENAQKFKTKFEE CCHHHHHHHHHHHHH | 46.55 | 19608861 | |
150 | Ubiquitination | LNAENAQKFKTKFEE CCHHHHHHHHHHHHH | 46.55 | 21890473 | |
152 | Acetylation | AENAQKFKTKFEECR HHHHHHHHHHHHHHH | 58.82 | 20167786 | |
154 | Acetylation | NAQKFKTKFEECRKE HHHHHHHHHHHHHHH | 51.90 | 23749302 | |
154 | Ubiquitination | NAQKFKTKFEECRKE HHHHHHHHHHHHHHH | 51.90 | - | |
160 | Acetylation | TKFEECRKEIEEREK HHHHHHHHHHHHHHH | 74.77 | 30583473 | |
179 | Acetylation | GKNDHAEKVAEKLEA CCCHHHHHHHHHHHH | 47.75 | 25953088 | |
182 | Ubiquitination | DHAEKVAEKLEALSV HHHHHHHHHHHHHCC | 62.25 | 21890473 | |
182 | Ubiquitination | DHAEKVAEKLEALSV HHHHHHHHHHHHHCC | 62.25 | 19608861 | |
182 | Acetylation | DHAEKVAEKLEALSV HHHHHHHHHHHHHCC | 62.25 | 19608861 | |
183 | Ubiquitination | HAEKVAEKLEALSVK HHHHHHHHHHHHCCC | 41.72 | 21906983 | |
183 | Acetylation | HAEKVAEKLEALSVK HHHHHHHHHHHHCCC | 41.72 | 19608861 | |
188 | Phosphorylation | AEKLEALSVKEETKE HHHHHHHCCCHHHHH | 37.89 | 23401153 | |
190 | Acetylation | KLEALSVKEETKEDA HHHHHCCCHHHHHHH | 46.59 | 26051181 | |
190 | Ubiquitination | KLEALSVKEETKEDA HHHHHCCCHHHHHHH | 46.59 | - | |
190 | Sumoylation | KLEALSVKEETKEDA HHHHHCCCHHHHHHH | 46.59 | 28112733 | |
190 | Sumoylation | KLEALSVKEETKEDA HHHHHCCCHHHHHHH | 46.59 | - | |
193 | Phosphorylation | ALSVKEETKEDAEEK HHCCCHHHHHHHHHH | 40.60 | 30108239 | |
194 | Acetylation | LSVKEETKEDAEEKQ HCCCHHHHHHHHHHC | 57.80 | 26051181 | |
200 | Acetylation | TKEDAEEKQ------ HHHHHHHHC------ | 53.46 | 30583485 | |
265 | Phosphorylation | ----------------------------------------------------------------------- ----------------------------------------------------------------------- | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RANG_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RANG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RANG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
IMB1_HUMAN | KPNB1 | physical | 10473610 | |
RAN_HUMAN | RAN | physical | 10811801 | |
XPO1_HUMAN | XPO1 | physical | 10601307 | |
RAN_HUMAN | RAN | physical | 10779340 | |
IMB1_HUMAN | KPNB1 | physical | 10779340 | |
RAN_HUMAN | RAN | physical | 9111043 | |
MDM2_HUMAN | MDM2 | physical | 12393906 | |
RAN_HUMAN | RAN | physical | 22939629 | |
RCC1_HUMAN | RCC1 | physical | 22939629 | |
RNA1_SCHPO | rna1 | physical | 11832950 | |
IDHC_HUMAN | IDH1 | physical | 22863883 | |
PLST_HUMAN | PLS3 | physical | 22863883 | |
HERC5_HUMAN | HERC5 | physical | 24693865 | |
VATD_HUMAN | ATP6V1D | physical | 26344197 | |
GOLP3_HUMAN | GOLPH3 | physical | 26344197 | |
RAB1A_HUMAN | RAB1A | physical | 26344197 | |
RAN_HUMAN | RAN | physical | 26344197 | |
RNB3L_HUMAN | RANBP3L | physical | 26344197 | |
TADBP_HUMAN | TARDBP | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-60, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150 AND LYS-183, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-60, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; THR-13; SER-14;THR-18 AND SER-21, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-14; THR-15;THR-18 AND SER-21, AND MASS SPECTROMETRY. |